Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services
Yesenia Aponte-Meléndez, Pedro Mateu‐Gelabert, Chunki Fong, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Covid-19 and alcohol associated liver disease
Sasha Deutsch‐Link, Brenda Curtis, Ashwani K. Singal
Digestive and Liver Disease (2022) Vol. 54, Iss. 11, pp. 1459-1468
Open Access | Times Cited: 40
High levels of all-cause mortality among people who inject drugs from 2018 to 2022
Sotirios Roussos, Theodoros Angelopoulos, Εvangelos Cholongitas, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104356-104356
Closed Access | Times Cited: 9
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
Tyler S. Bartholomew, Barbara Andraka-Cristou, Rachel Totaram, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium
Ellen Brazier, Rogers Ajeh, Fernanda Maruri, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. 12
Open Access | Times Cited: 25
Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience
Omeid Heidari, Diane Meyer, Kelly Lowensen, et al.
Health Affairs (2024) Vol. 43, Iss. 6, pp. 883-891
Closed Access | Times Cited: 5
Integration of a community-based harm reduction program into a safety net hospital: a qualitative study
Ghulam Karim Khan, Leah Harvey, Samantha Johnson, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 22
A Qualitative Study Exploring Access to Mental Health and Substance Use Support among Individuals Experiencing Homelessness during COVID-19
Emma A. Adams, Jeff Parker, Tony Jablonski, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 6, pp. 3459-3459
Open Access | Times Cited: 20
Health service utilisation and access for people who inject drugs during COVID‐19
Henrietta Efunnuga, Peter Higgs, Shelley Walker, et al.
Drug and Alcohol Review (2022) Vol. 41, Iss. 6, pp. 1304-1310
Open Access | Times Cited: 19
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago
Kathleen Kristensen, Basmattee Boodram, Wendy D. Martinez-Avila, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0293238-e0293238
Open Access
Estimating the Cost-Saving Threshold of a Rural Syringe Services Program Before and During the COVID-19 Pandemic
Sean T. Allen, Brian W. Weir, Molly C. Reid, et al.
AIDS and Behavior (2025)
Closed Access
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022
Eshan U. Patel, Jacqueline E. Rudolph, Kenneth A. Feder, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104746-104746
Closed Access
Representative national survey on drug use during the COVID-19 stay-at-home order in the USA
Soo‐Hoon Lee, Bernadette Cullen, Alison Athey, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e086141-e086141
Open Access
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA
Magally Torres-Leguizamon, Jamie Favaro, Dan Coello, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
A new outbreak of HIV infection among people who inject drugs during the COVID-19 pandemic in Greece
Vana Sypsa, Sotirios Roussos, Efrossini Tsirogianni, et al.
International Journal of Drug Policy (2023) Vol. 117, pp. 104073-104073
Open Access | Times Cited: 9
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in Massachusetts, USA
Xiao Zang, Alexander Y. Walley, Avik Chatterjee, et al.
Addiction (2023) Vol. 118, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 9
Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland
Eshan U. Patel, Suzanne M. Grieb, Abigail K. Winiker, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Lucas Wiessing, Vana Sypsa, Adrian Abagiu, et al.
AIDS and Behavior (2022) Vol. 27, Iss. 4, pp. 1140-1153
Open Access | Times Cited: 15
The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study
Mercy Ude, Czarina N. Behrends, Shea Kelly, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky
Jennifer L. Glick, Suzanne M. Grieb, Samantha J. Harris, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 13
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state
Kinna Thakarar, Michael Kohut, Rebecca Hutchinson, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria
Roberto Abadie, Manuel Cano, Patrick Habecker, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 13
“A lotta people switched playing hard ball to playing Russian roulette”: Experiences with rising overdose incidence caused by drug supply changes during the COVID-19 pandemic in the San Diego-Tijuana border metroplex
Chad J. Valasek, Samantha Streuli, Heather A. Pines, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100154-100154
Open Access | Times Cited: 7
Assessing the Impact of COVID-19 on HIV Outcomes in the United States: A Modeling Study
Alex Viguerie, Evin Uzun Jacobson, Katherine A. Hicks, et al.
Sexually Transmitted Diseases (2024) Vol. 51, Iss. 4, pp. 299-304
Closed Access | Times Cited: 2
Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study
Richard L. Morrow, Mawuena Binka, Julia Li, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 655-655
Open Access | Times Cited: 2
Barriers and facilitators to becoming an alcohol and other drug nurse practitioner in Australia: A mixed methods study
Adam Searby, Dianna Burr, Colleen Blums, et al.
International Journal of Mental Health Nursing (2023) Vol. 32, Iss. 3, pp. 839-853
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top